Autism - Biotech, Pharma and Life Science Channel
Autism affects half a million people in the UK. Men are affected more than women.
People with autism have said that the world, to them, is a mass of people, places and events which they struggle to make sense of, and which can cause them considerable anxiety.
Autism is a lifelong developmental disability. It is part of the autism spectrum and is sometimes referred to as an autism spectrum disorder, or an ASD, because, while all people with autism share three main areas of difficulty, their condition will affect them in very different ways. Aspergers syndrome is on this spectrum.
The three main areas of difficulty which all people with autism share are sometimes known as the 'triad of impairments'. They are:
* difficulty with social communication
* difficulty with social interaction
* difficulty with social imagination.
The exact cause of autism is unknown, but research suggests that it is multi-factorial changes in brain development.
Although there is currently no 'cure', there are a range of approaches to cope with the disease. This include conventional medications, as well as dietary and complimentary treatments and behavioral interventions.
Source; Adapted from The National Autistic Society
Add the Autism News Channel to your RSS reader;
Follow the Autism Twitter Feed;
News Articles
HARRISBURG, Pa., May 16, 2013 /PRNewswire-USNewswire/ -- A 2008 law will soon require staff serving children with autism spectrum disorders to hold a Behavior Specialist license in order to continue b...
Combining Ground-Breaking Innovation and the Highest Safety Standards in the World, Springfree Trampoline to Participate in Various Autism Speaks Initiatives, Including National W...
CARY, N.C., May 14, 2013 /PRNewswire/ -- National Autism Network launches the most comprehensive and up to date website (www.nationalautismnetwork.com), available for individuals, fam...
Autism Symposium June 1 at Stanford University, Sponsored by Packard Children's Hospital
Raising a child with autism can leave parents with big questions, both at the time of diagnosis and in the years that follow. Prominent among them: What do I need to do when my ch...
Autism Speaks and Dee Ocleppo Celebrate Mothers in Autism Community at “Mom 4 Moms” Luncheon
Autism Speaks, the world’s leading autism science and advocacy organization, hosted a Mother’s Day “Moms 4 Moms” luncheon at The Lambs Club in New York City Wednesday, M...
Pat Levitt, PhD, international autism expert, will lead research into the role of genes and the environment on the developing brain The internationally renowned expert in neur...
Abnormal growth rate in womb linked to autism
'Babies that are abnormally heavy or underweight are at 62% greater risk' of developing autism, reports the Daily Mail. The news is based on a large study of Swedish children with and without autism...
TSC Global Awareness Day Scheduled for May 15
SILVER SPRING, Md., May 2, 2013 /PRNewswire-USNewswire/ -- On May 15, the Tuberous Sclerosis Alliance (TS Alliance) will join tuberous sclerosis complex (TSC) organizations around the worl...
Seaside Therapeutics announces that the results of its Phase 2b trial evaluating arbaclofen (STX209) to treat core impairments of autism spectrum disorder (ASD) will be presented...
NEW HAVEN, Conn., April 30, 2013 /PRNewswire/ -- Autism Speaks and Prometheus Research have teamed up to develop a new, more user-friendly assessment portal through which parents can complete surveys...
Events
None
Companies
Lineagen (www.lineagen.com) is a provider of diagnostic and healthcare services focused on complex diseases for which individualsâ genetic profiles contribute strongly to...
Tobii Assistive Technology Inc.
Tobii Assistive Technology Inc., a wholly owned subsidiary of Tobii Technology, is a leading provider of eye-tracking-based augmented and alternative communication (AAC) devices t...
SynapDx is a private company providing laboratory diagnostic services to physicians who suspect children of developmental disorders, with the initial goal of enabling earli...
Population Diagnostics, Inc. (PDx, www.populationdiagnostics.com) is applying its discoveries in human genetics to the development of DNA-based diagnostics and personalized medici...
MicroTransponder (www.microtransponder.com) is developing a wireless neurostimulation system for the treatment of chronic pain and several other neurological indications. The mini...
Seaside Therapeutics, Inc. is creating novel drug treatments to correct or improve the course of fragile X syndrome, autism and other neurodevelopmental disorders. The Company is...
IntegraGen (www.integragen.com) is a biotechnology company dedicated to gene discovery with the goal of developing molecular diagnostic products and services that provide c...
Autism is a complex neurobiological disorder that inhibits a person's ability to communicate and develop social relationships, and is often accompanied by behavioral challenges. A...
Seaside Therapeutics is creating novel drug treatments to correct or improve the course of Fragile X Syndrome, autism and other disorders of brain development. We are dedicated to...
Clinical Trials
Omega-3 Fatty Acids in Autism Spectrum Disorders
This is a 12-week open label trial to evaluate whether omega-3 fatty acids is effective in reducing the severity of autism and its comorbidities.
Autism, originally described by Kanner (1943), is among the most severe of neuropsychiatric disorders. It is a pervasive developmental disorder affecting social, communicative, and compuls...
Aripiprazole in Children With Autism: A Pilot Study
This is a 6-week open pilot study of aripiprazole for the treatment of adolescents, aged 12 to 18 years, diagnosed with autism. Children who qualify for the study will be treated with ari...
A Controlled Study of Olanzapine in Children With Autism
This is a 12-week study which investigates the use of olanzapine to decrease disruptive behaviors sometimes associated with Autism in children, aged 3 to 12 years old. The first six weeks...
Effects of CX516 on Functioning in Fragile X Syndrome and Autism
This study will investigate whether CX516 can improve attention, memory, language, or behavior in adults with Fragile X Syndrome and/or Autism. CX516 is an AMPAKINE® compound. AMPAKINE...
Behavior in Children With Attention Deficit Hyperactivity Disorder and in Healthy Volunteers
The purpose of this study is to determine how the brain controls motor activity in children with attention deficit hyperactivity disorder (ADHD). The inability to control one's behavior i...
Treatment of Autism in Children and Adolescents
This study is designed to determine the effectiveness of risperidone, a drug treatment for the interfering symptoms of Autistic Disorder in children and adolescents between the ages of 5 a...
Longitudinal and Biological Study of Childhood Disintegrative Disorder
OBJECTIVES: I. Compare the developmental course (language acquisition, diagnostic stability, predictors of outcome, and restricted interests and behaviors) of childhood disintegrative di...
OBJECTIVES: I. Determine the effectiveness of intensive one-on-one behavioral treatment in the home or neighborhood compared with at home, individualized, parent training in preschool age...
Testing a Possible Cause of Reduced Ability of Children to Process Speech in Noise
This study aims to increase our understanding of the difficulty people have recognizing the spoken word, especially in noisy situations. Subjects must be between 12 and 18 years old with...
PubMed Articles
Preliminary Findings of a Telehealth Approach to Parent Training in Autism.
Telehealth or online communication technologies may lessen the gap between intervention requirements for children with autism spectrum disorders (ASDs) and the available resources to provide these ser...
Epigenomic strategies at the interface of genetic and environmental risk factors for autism.
Autism spectrum disorders (ASD) have been increasing in prevalence over the last two decades, primarily because of increased awareness and diagnosis. However, autism is clearly a complex human genetic...
The serotonin transporter (SERT) is involved in various psychiatric disorders, including depression and autism. Recently, chemical chaperones have been focused as potential therapeutic drugs that can...
Findings that a subgroup of children with an autism spectrum disorder (ASD) have linguistic capabilities that resemble specific language impairment (SLI) have led some authors to hypothesise that ASD...
BACKGROUND: Substantial overlap has been reported between attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Deficits in executive function (EF) are characteristic of...
A Danish population-based twin study on autism spectrum disorders.
Genetic epidemiological studies of Autism Spectrum Disorders (ASDs) based on twin pairs ascertained from the population and thoroughly assessed to obtain a high degree of diagnostic validity are few....
Prenatal and perinatal analgesic exposure and autism: an ecological link.
BACKGROUND: Autism and Autism Spectrum Disorder (ASD) are complex neurodevelopmental disorders. Susceptibility is believed to be the interaction of genetic heritability and environmental factors. The...
PURPOSE: We used Taiwan's population-based National Health Insurance database to investigate the trends, correlates, and disease patterns of antipsychotic use among children and adolescents. METHODS:...
This cross-sectional study seeks to (a) describe developmental correlates of sensory hyporesponsiveness to social and nonsocial stimuli, (b) determine whether hyporesponsiveness is generalized across...
Videos
Flatline - Autism Song "When The Children Cry" - Official Compound Film
Flatline - "When The Children Cry" - Official Compound Film THIS A SONG I WROTE FOR MY 9 YEAR OLD SON "TREY" WHO HAS AUTISM. HE IS MY WORLD! MY MISSION IN LI...
Medical and Biotech [MESH] Definitions
Asperger Syndrome
A childhood disorder predominately affecting boys and similar to autism (AUTISTIC DISORDER). It is characterized by severe, sustained, clinically significant impairment of social interaction, and restricted repetitive and stereotyped patterns of behavior. In contrast to autism, there are no clinically significant delays in language or cognitive development. (From DSM-IV)
